chr15-23129937-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001001413.3(GOLGA6L1):c.1516G>A(p.Asp506Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001413.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000173 AC: 2AN: 115604Hom.: 0 Cov.: 20
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000361 AC: 20AN: 553798Hom.: 0 Cov.: 7 AF XY: 0.0000339 AC XY: 10AN XY: 294698
GnomAD4 genome AF: 0.0000173 AC: 2AN: 115604Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 55570
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1516G>A (p.D506N) alteration is located in exon 8 (coding exon 8) of the GOLGA6L1 gene. This alteration results from a G to A substitution at nucleotide position 1516, causing the aspartic acid (D) at amino acid position 506 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at